Disclaimer: This is a user generated content submitted by a member of the WriteUpCafe Community. The views and writings here reflect that of the author and not of WriteUpCafe. If you have any complaints regarding this post kindly report it to us.

  Immune checkpoint inhibitors are a type of immunotherapy drug. Although traditional chemotherapeutic drugs are still the first-line treatment option for most cancer types, targeted immune therapies are becoming standard treatments for advanced-stage cancers. These drugs target cell surface checkpoint proteins to stimulate the immune system's recognition and destruction of cancer cells.

  The global immune checkpoint inhibitors market is growing due to an increase in cancer prevalence across geographies and increased awareness of immune checkpoint inhibitors. Furthermore, technological advancements in cancer screening procedures, increased healthcare expenditures, an increase in government initiatives to alleviate cancer, and an increase in public awareness is expected to drive market growth. However, the high cost of research activities is expected to limit Immune checkpoint inhibitors' growth.

  Because of the global increase in lung cancer prevalence, the lung cancer segment currently dominates the market and is expected to remain dominant during the forecast period. The increased use of immune checkpoint inhibitors in the treatment of non-small cell lung cancer (NSCLC) also contributes to the growth of this segment. Furthermore, an increase in the geriatric population, an increase in the cigarette smoking population, and advancements in lung cancer diagnostic techniques all contribute to growth.

Read more @ https://bit.ly/3GZtarZ

0

Login

Welcome to WriteUpCafe Community

Join our community to engage with fellow bloggers and increase the visibility of your blog.
Join WriteUpCafe